Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
University of California at Davis
Davis, California
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 418
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Craig McDonald | Financial Disclosure | Revera Gen BioPharma | 2016 | |
| Craig M. McDonald | Financial Disclosure | Sarepta Therapeutics | 2016 | |
| Craig M. McDonald | Financial Disclosure | Sarepta Therapeutics | 2017 | |
| Craig M. McDonald | Financial Disclosure | Biomarin Pharmaceutical Inc | 2016 | |
| Craig McDonald | Financial Disclosure | Revera Gen BioPharma | 2016 | |
| Brian M. Morrissey | Financial Disclosure | Boehringer Ingelheim | 2016 | |
| Brian Morrissey | Financial Disclosure | Celtaxsys Inc | 2016 | |
| Christopher J. Murphy | Financial Disclosure | Ocular Services On Demand | 2016 | |
| Patricia Oteiza | Financial Disclosure | NSE Products Inc/NuSkin | 2016 | |
| Robert Powell | Financial Disclosure | Mars Inc. | 2016 | |
| Robert L. Powell | Financial Disclosure | Lawrence Livermore National Lab | 2016 | |
| Sarah Toby Stewart-Mukhopadhyay | Financial Disclosure | Lawrence Livermore National Laboratory | 2016 | |
| Ilias Tagkopoulos | Financial Disclosure | Mars | 2016 | |
| Joseph Tuscano | Financial Disclosure | Celgene, Inc | 2016 | |
| Joseph Tuscano | Financial Disclosure | Celgene, Inc | 2016 | |
| David L. Woodruff | Financial Disclosure | Sandia National Laboratories | 2016 | |
| David L. Woodruff | Financial Disclosure | Sandia National Laboratories | 2016 | |
| Edward Kim | Financial Disclosure | Pharmacyclics LLC | 2016 | |
| David Randal Hessl | Financial Disclosure | National Fragile X Foundation | 2016 | |
| David Randal Hessl | Financial Disclosure | National Fragile X Foundation | 2016 | |
| Jay A. Rosenheim | Financial Disclosure | Almond Board of California | 2015 | |
| Johan Hj Leveau | Financial Disclosure | BioN2 | 2016 | |
| Peter Belafsky | Financial Disclosure | Cook Myosite Inc. | 2016 | |
| Kyria Boundy-Mills | Financial Disclosure | Mars | 2016 | |
| Christopher L. Bowlus | Financial Disclosure | Intercept Pharmaceuticals, Inc | 2016 | |
| Christopher L. Bowlus | Financial Disclosure | Intercept Pharmaceuticals, Inc | 2016 | |
| Brian Morrissey | Financial Disclosure | Savara Inc. | 2017 | |
| Christopher L. Bowlus | Financial Disclosure | Intercept Pharmaceuticals, Inc | 2016 | |
| Christopher L. Bowlus | Financial Disclosure | Intercept Pharmaceuticals, Inc | 2016 | |
| Craig M. McDonald | Financial Disclosure | Sarepta Therapeutics | 2017 | |
| Christopher Evans | Financial Disclosure | Genzyme Corporation (subsidiary of Sanofi) | 2016 | |
| Christopher P. Evans | Financial Disclosure | Astellas Pharma Global Development Inc | 2016 | |
| Christopher P. Evans | Financial Disclosure | Ferring Pharmaceuticals A/S | 2016 | |
| Christopher Evans | Financial Disclosure | Sanofi | 2016 | |
| M Saiful Islam | Financial Disclosure | Atocera, Inc. | 2016 | |
| Kee D. Kim | Financial Disclosure | InVivo Therapeutics Corporation | 2016 | |
| Larissa S. May | Financial Disclosure | Cepheid | 2016 | |
| Hien H. Nguyen | Financial Disclosure | Merck Sharp & Dohme Corp., a subsidiary of Merck & | 2016 | |
| Stephen D. O'Driscoll | Financial Disclosure | Google Inc | 2016 | |
| Richard Byrd Pollard | Financial Disclosure | Gilead Sciences, Inc. | 2016 | |
| Richard B. Pollard | Financial Disclosure | Gilead Sciences, Inc. | 2016 | |
| Richard Byrd Pollard | Financial Disclosure | Gilead Sciences, Inc. | 2016 | |
| Jason H. Rogers | Financial Disclosure | Abbott Vascular, Inc. | 2016 | |
| Elena O. Siegel | Financial Disclosure | Refer to Statement A | 2016 | |
| Elena O. Siegel | Financial Disclosure | National Council of State Boards of Nursing | 2016 | |
| Elena O. Siegel | Financial Disclosure | National Association of Long Term Care Administrator Boards | 2016 | |
| Raja K. Sivamani | Financial Disclosure | Valeant Pharm North America | 2016 | |
| Vivek J. Srinivasan | Financial Disclosure | Glaucoma Research Foundation | 2015 | |
| Ted Wun | Financial Disclosure | Janssen Scientific Affairs | 2016 | |
| Sarah Stewart-Mukhopadhyay | Financial Disclosure | Lawrence Livermore National Security, LLC | 2018 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.